These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 37631054)

  • 1. Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders.
    Hang A; Feldman S; Amin AP; Ochoa JAR; Park SS
    Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel model of persistent retinal neovascularization for the development of sustained anti-VEGF therapies.
    Li Y; Busoy JM; Zaman BAA; Tan QSW; Tan GSW; Barathi VA; Cheung N; Wei JJ; Hunziker W; Hong W; Wong TY; Cheung CMG
    Exp Eye Res; 2018 Sep; 174():98-106. PubMed ID: 29852133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis.
    Pham B; Thomas SM; Lillie E; Lee T; Hamid J; Richter T; Janoudi G; Agarwal A; Sharpe JP; Scott A; Warren R; Brahmbhatt R; Macdonald E; Straus SE; Tricco AC
    BMJ Open; 2019 May; 9(5):e022031. PubMed ID: 31142516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent trends in anti-vascular endothelial growth factor intravitreal injections: a large claims database study in Japan.
    Hashimoto Y; Okada A; Matsui H; Yasunaga H; Aihara M; Obata R
    Jpn J Ophthalmol; 2023 Jan; 67(1):109-118. PubMed ID: 36508060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D; Bunce C; Charteris D
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
    Eyetech Study Group
    Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of dialysis in patients receiving intravitreal anti-vascular endothelial growth factor treatment: a population-based cohort study.
    Yang SF; Su YC; Lim CC; Huang JY; Hsu SM; Wu LW; Chang YS; Hung JH
    Aging (Albany NY); 2022 Jun; 14(12):5116-5130. PubMed ID: 35724264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New drug VEGF Trap-Eye--Eylea--and its use in the treatment of age-related macular degeneration, central retinal vein occlusion, diabetic macular edema, and choroidal neovascularization secondary to pathologic myopia].
    Rejdak R; Szkaradek M; Taslaq W; Kałuzny JJ; Grieb P; Jünemann AG
    Klin Oczna; 2012; 114(4):308-10. PubMed ID: 23461161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal Anti Vascular Endothelial Growth Factor Agents in The Management of Retinal Diseases: An Audit.
    Fiebai B; Odogu V
    Open Ophthalmol J; 2017; 11():315-321. PubMed ID: 29299078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does laser still have a role in the management of retinal vascular and neovascular diseases?
    Shah AM; Bressler NM; Jampol LM
    Am J Ophthalmol; 2011 Sep; 152(3):332-339.e1. PubMed ID: 21742309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
    Smith JM; Steel DH
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD008214. PubMed ID: 26250103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What can anti-VEGF therapy achieve in clinical routine? : Effectiveness of anti-VEGF therapy in patients with macular diseases in clinical routine on 1492 eyes in Austria].
    Wiesinger K; Reinelt P; Ennemoser A; Edelmayr M; Schönherr U
    Ophthalmologe; 2017 Jul; 114(7):639-645. PubMed ID: 27815675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Shalchi Z; Mahroo O; Bunce C; Mitry D
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
    Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
    N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration: A Post Hoc Analysis of the VIEW Studies.
    Steinle NC; Du W; Gibson A; Saroj N
    Ophthalmol Retina; 2021 Feb; 5(2):141-150. PubMed ID: 32652314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aging and retinal vascular diseases].
    Takagi H
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):207-30; discussion 231. PubMed ID: 17402563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subretinal hemorrhage after intravitreal injection of anti-VEGF for age-related macular degeneration: a retrospective study].
    Baeteman C; Hoffart L; Galland F; Ridings B; Conrath J
    J Fr Ophtalmol; 2009 May; 32(5):309-13. PubMed ID: 19769866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin.
    Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L
    Elife; 2020 Apr; 9():. PubMed ID: 32312382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-vascular endothelial growth factor therapy for ocular neovascular disease.
    Andreoli CM; Miller JW
    Curr Opin Ophthalmol; 2007 Nov; 18(6):502-8. PubMed ID: 18163003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intraocular antiangiogenic drugs in clinical application advantages and disadvantages].
    Li XX
    Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):870-3. PubMed ID: 23302238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.